Australian Ethical Health Alliance

The Australian Ethical Health Alliance (AEHA) was formed in April 2019 to oversee implementation of the Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector. This is a consensus of shared values and ethical principles that form the basis of collaboration and interaction among organisations in the Australian healthcare sector. The sector-led initiative has 70+ member organisations representing:

Last updated: 27.04.2021

This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.

Consensus Framework for Ethical Collaboration between Patients’ Organisations, Healthcare Professionals and the Pharmaceutical Industry

The Consensus Framework for Ethical Collaboration was established in 2014 as a platform for ethical collaboration between patients’ organisations, healthcare professionals and the pharmaceutical industry. The ultimate aim is to improve the quality of patient care. 

It has four overarching principles: 

  • Put Patients First
  • Support Ethical Research and Innovation
  • Ensure Independence and Ethical Conduct
  • Promote Transparency and Accountability

The Consensus Framework is supported by:

Last updated: 09.08.2021

This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.

Business Ethics for APEC SMEs Initiative

This Business Ethics for APEC SMEs Initiative is a public-private partnership with the aim of strengthening ethical business practices in the medical device and biopharmaceutical sectors. It is overseen by the US Department of Commerce and is supported by member economies of the Asia-Pacific Economic Cooperation forum (APEC).

Last updated: 22.06.2020

This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.

Mapping anti-corruption authorities around the world – Q&A with the French Anti-Corruption Agency

The recently published Global Mapping of Anti-Corruption Authorities fills a critical gap in information about national anti-corruption authorities (ACAs) around the world. ACAs are key institutions to prevent and combat corruption, but until now centralised data on their mandates, activities and even existence has been lacking.

Pandemic highlights the potential of Collective Action for integrity in healthcare

The global disruption from covid-19 to health and economic systems has magnified risks to preserving business integrity that will have longstanding impact. As a result, the pandemic is drawing significant attention to several of the world’s largest Collective Action initiatives that are reinforcing ethical business conduct in healthcare. The timing and actions of these initiatives could not be more critical in our crisis recovery efforts.

Quick Guide 18: Mobile money and financial crime

The amount of money flowing through mobile payment systems such as M-Pesa, MTN Mobile Money and Orange Money has exploded, in part due to covid-19 lockdowns. Should we be worried about the use of mobile money for financial crimes? 

In this quick guide, Andrew Dornbierer explains how mobile money could be abused for corruption and money laundering. Drawing on on-the-ground experience in Sub-Saharan Africa, he also outlines how law enforcement officers can take advantage of this widespread payment method to catch corruption and money laundering schemes and prove them in court. 

Quick Guide 17: Open-source intelligence

Anti-corruption, transparency and freedom of information initiatives over the last decades have significantly boosted the value of open-source intelligence for both the private and public sectors.

In this quick guide, Intelligence Analyst Manuel Medina explains what open-source intelligence is and explores some of the tricky questions it raises. 

A fast way to identify fraud risks and vulnerabilities: Proactive Integrity Reviews  

In this guest article, Duncan Smith and Dominik Adamski of the European Investment Bank's Fraud Investigations Team explain how risk-based Proactive Integrity Reviews have helped to uncover vulnerabilities and fraud risks in EIB-funded projects. The General Principles are available for anyone to adapt and use.

Upcoming UK government webinars on Top Tips for Trading Responsibly During Covid-19

Integrity risks for businesses trading overseas have shot up due to the pandemic. Anti-corruption and human rights compliance approaches designed to protect companies during “business as usual” can come under strain in these unusual circumstances.

How can companies – especially smaller companies with limited resources – protect themselves from integrity risks in these times of crisis? There are no easy answers, but it’s important to talk about the questions.